Articles Referencing CNS

Zacks.com

Data on Teva's Azilect - Analyst Blog

Teva Pharmaceutical ( TEVA ) and H. Lundbeck A/S recently presented positive data on Azilect from a double-blind, placebo controlled, randomized, multicenter study. Teva and H. Lundbeck... Read >>

NASDAQ.com News

Cohn & Steers Inc (CNS) Ex-Dividend Date Scheduled for March 25, 2013

Cohn & Steers Inc ( CNS ) will begin trading ex-dividend on March 25, 2013. A cash dividend payment of $0.2 per share is scheduled to be paid on April 12, 2013. Shareholders who... Read >>

Zacks.com

UCB, Five Prime Collaborate - Analyst Blog

UCB ( UCBJF ) recently announced a strategic deal with Five Prime Therapeutics, Inc. for the discovery of innovative biologics targets and therapeutics for fibrosis-related inflammatory... Read >>

Zacks.com

Legg Mason Acquires Fauchier - Analyst Blog

Asset Management company, Legg Mason ( LM ) together with its affiliate, Permal Group announced the successful completion of its acquisition of London-based fund-of-hedge-funds firm -... Read >>

Zacks.com

FINRA Fines Ameriprise & Affiliate - Analyst Blog

The Financial Industry Regulatory Authority (FINRA) has penalized Ameriprise Financial Inc. ( AMP ) and it's clearing firm, American Enterprise Investment Services Inc., (AEIS)... Read >>

Zacks.com

Brookfield Redeeming Notes - Analyst Blog

Brookfield Asset Management Inc. ( BAM ) has announced the redemption price of 8.95% Notes worth the principal amount of C$150 million. These notes will be redeemed on Mar 6, 2013. These... Read >>

Zacks.com

Zacks Rank #1 Addition for Monday - Tale of the Tape

Here are 5 stocks added to the Zacks Rank #1 ("strong buy") List today: Amerisafe, Inc. ( AMSF ) Bridge Capital Holdings ( BBNK ) Churchill Downs, Inc. ( CHDN ) ... Read >>

Zacks.com

Brookfield Announces Strategic Deal - Analyst Blog

Toronto-based Brookfield Asset Management Inc. ( BAM ) announced the purchase of 19 apartment communities (4,892 units) in N.C., S.C. and Va. from Babcock & Brown Residential... Read >>

Zacks.com

Supernus' Update on Oxtellar - Analyst Blog

Supernus Pharmaceuticals, Inc. ( SUPN ) recently provided information on its agreement with Patheon Inc. ( PNHNF ) for the manufacture, formulation, development and supply... Read >>

Zacks.com

Lazard Beats Estimates, Expenses Up - Analyst Blog

Lazard Ltd. 's ( LAZ ) fourth-quarter 2012 adjusted earnings reached 61 cents per share, significantly beating the Zacks Consensus Estimate of 33 cents. Moreover, results compare favorably... Read >>

Zacks.com

Oxtellar XR Launched by Supernus - Analyst Blog

Supernus Pharmaceuticals, Inc. ( SUPN ) recently announced the launch of its antiepileptic drug, Oxtellar XR, in the US. Oxtellar XR was approved by the US Food and Drug... Read >>

Zacks.com

Affiliated Managers Beats on EPS - Analyst Blog

Affiliated Managers Group, Inc. 's ( AMG ) fourth quarter 2012 economic net income (ENI) came in at $2.55 per share, beating the Zacks Consensus Estimate of $2.43. Moreover, this... Read >>

StreetAuthority

Why The Rest of the World is Pouring Billions Into the U.S. Real Estate Market

Yngve Slyngstad and Peter Ballon aren't well-known names in the U.S. investment  community, but their decisions are having a multi-billion dollar effect on a key asset class... Read >>

David Sterman

Why The Rest of the World is Pouring Billions Into the U.S. Real Estate Market

Yngve Slyngstad and Peter Ballon aren't well-known names in the U.S. investment  community, but their decisions are having a multi-billion dollar effect on a key asset class... Read >>

NASDAQ.com News

Cohn & Steers Inc (CNS) Ex-Dividend Date Scheduled for November 28, 2012

Cohn & Steers Inc ( CNS ) has announced an ex-dividend date of November 28, 2012 and a cash dividend payment of $1.68 per share scheduled for December 20, 2012. Shareholders who... Read >>

Displaying 1-15 of 19
<< first < previous 1 2 next > last >>